3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Colorectal Neoplasms
2
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Interventions
Etoposide
23
Cisplatin
15
Carboplatin
13
Irinotecan
12
apatinib
11
anlotinib
10
durvalumab
7
Topotecan
6
toripalimab
4
surufatinib
4
sintilimab
4
atezolizumab
4
Temozolomide
4
Drug Therapy
4
tislelizumab
3
lobaplatin
3
camrelizumab
3
Simvastatin
3
Radiotherapy
3
Ifosfamide
3
Albumin-Bound Paclitaxel
3
pembrolizumab
2
pegylated granulocyte colony-stimulating factor
2
olaparib
2
niraparib
2
isophosphamide mustard
2
avelumab
2
X-Rays
2
Platinum
2
Nivolumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Small Cell Lung Carcinoma
×
polysaccharide-K
×
Clear all
NCT00546130
2008-09-03
RNCLC
University of Toyama
Phase 2
Unknown
45 enrolled